yellow diarrhea semaglutide GLP-1 Weight-Loss Medication Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are popular treatments for obesity. The authors discuss the kind of Ozempic and GLP-1 Drugs: Risk

Nature Cell Biology , 26 (11), 18921902

Find Out More Who is Shawn Wells

The Retatrutide products were purchased online, through friends, and through social media ads marketed for muscle growth, fat loss, recovery and anti-ageing, the Victorian Health Department confirmed

Retatrutide Dosing Guidelines : Begin with 2 mg weekly for the first 4 weeks to minimize potential side effects

Per the same safety document, the most commonly reported side effects are typically mild and tend to resolve after the first several weeks: nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, reflux, headache, fatigue, and dizziness, along with possible injection-site swelling, redness, or itchiness